Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study-Reference-Cited by-同舟云学术

Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study

Published:2023-01 Issue: Volume:24 Page:100547
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Zaballa María-Eugenia,Perez-Saez Javier,de Mestral Carlos^ORCID,Pullen Nick,Lamour Julien^ORCID,Turelli Priscilla^ORCID,Raclot Charlène^ORCID,Baysson Hélène,Pennacchio Francesco,Villers Jennifer,Duc Julien^ORCID,Richard Viviane,Dumont Roxane,Semaani Claire,Loizeau Andrea Jutta,Graindorge Clément,Lorthe Elsa^ORCID,Balavoine Jean-François,Pittet Didier,Schibler Manuel,Vuilleumier Nicolas,Chappuis François,Kherad Omar^ORCID,Azman Andrew S.^ORCID,Posfay-Barbe Klara M.,Kaiser Laurent,Trono Didier,Stringhini Silvia,Guessous Idris,Arm-Vernez Isabelle,Azman Andrew S,Bachmann Delphine,Bal Antoine,Balavoine Jean-François,Balavoine Michael,Barbe Rémy P,Baysson Hélène,Beigbeder Lison,Berthelot Julie,Bleich Patrick,Boehm Livia,Bryand Gaëlle,Chappuis François,Collombet Prune,Coudurier-Boeuf Sophie,Courvoisier Delphine,Cudet Alain,Davidovic Vladimir,de Mestral Carlos,D'ippolito Paola,Dubos Richard,Dumont Roxane,Eckerle Isabella,El Merjani Nacira,Flahault Antoine,Francioli Natalie,Frangville Marion,Graindorge Clément,Guessous Idris,Harnal Séverine,Hurst Samia,Kaiser Laurent,Kherad Omar,Lamour Julien,Lescuyer Pierre,L'Huillier Arnaud G,L'Huissier François,Loizeau Andrea Jutta,Lorthe Elsa,Martinez Chantal,Ménard Lucie,Metral-Boffod Ludovic,Moulin Alexandre,Nehme Mayssam,Noël Natacha,Pennacchio Francesco,Perez-Saez Javier,Pittet Didier,Posfay-Barbe Klara M,Poulain Géraldine,Pugin Caroline,Pullen Nick,Richard Viviane,Rinaldi Frederic,Rochat Déborah,Sakvarelidze Irine,Samir Khadija,Ramirez Hugo Santa,Satin Etienne,Schaller Philippe,Schibler Manuel,Schrempft Stephanie,Semaani Claire,Stringhini Silvia,Testini Stéphanie,Trono Didier,Urrutia-Rivas Déborah,Verolet Charlotte,Vetter Pauline,Villers Jennifer,Violot Guillemette,Vuilleumier Nicolas,Wisniak Ania,Yerly Sabine,Zaballa María-Eugenia

Publisher

Elsevier BV

Subject

Health Policy,Oncology,Internal Medicine

Reference43 articles.

1. Interim statement on hybrid immunity and increasing population seroprevalence rates;World Health Organization,2022

2. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.;Bergeri;PLOS Medicine,2022

3. Update on SARS-CoV-2 seroprevalence: regional and worldwide;Rostami;Clin Microbiol Infect,2021

4. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects;Bonanad;J Am Med Dir Assoc,2020

5. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis;Liu;Aging Dis,2020

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-acute sequelae of SARS-CoV-2 mimic: An important neurological condition;Journal of the Neurological Sciences;2024-10

2. Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants;Proceedings of the National Academy of Sciences;2024-07-30

3. Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019;Clinical Infectious Diseases;2024-07-17

4. A cross-sectional study of SARS-CoV-2 antibodies among healthcare workers in a tertiary care hospital in Taiwan: implications for protection against the Omicron variants;BMC Infectious Diseases;2024-05-27

5. A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough Infection;Diagnostics;2024-04-16